Glucagon-like peptide 1 receptor agonists (GLP-1 RA) are a class of drug shown to reduce HbA1c with additional weight loss benefits in patients with and without T2D.14, 16 While emerging data shows GLP-1 RA use in overweight women with previous GDM is associated with weight reduction, long-term medication tolerability is a concern.17 Here, GLP1R is linked to gestational diabetes.